v3.26.1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2026
Jan. 31, 2025
Income Statement [Abstract]        
Revenue, net $ 1,383,941 $ 623,709 $ 1,468,941 $ 760,583
Cost of revenue (1,300,286) (379,081) (1,300,338) (428,362)
Gross profit 83,655 244,628 168,603 332,221
Operating expenses        
Selling expenses (14) (25,722) (1,314,182) (86,338)
General & administrative expenses (635,248) (134,823) (2,388,059) (942,574)
Total operating expenses (635,262) (160,545) (3,702,241) (1,028,912)
Income (loss) from operations (551,607) 84,083 (3,533,638) (696,691)
Other income (expenses)        
Other expenses (20,654) (2,168) (4,071) (2,168)
Interest income (expense) 36,143 (115) 35,390 (115)
Total other income (expenses), net 15,489 (2,283) 31,319 (2,283)
Income (loss) before income tax provision (536,118) 81,800 (3,502,319) (698,974)
Income tax provision (12,218) (1,574) (15,401) (4,668)
Net income (loss) from continuing operations (548,336) 80,226 (3,517,720) (703,642)
Net income (loss) from discontinued operations, net of tax (56,808) (646,656) 284,160
Net loss $ (548,336) $ 23,418 $ (4,164,376) $ (419,482)
Net loss per common stock        
Basic net loss per common stock (in Dollars per share) [1] $ (0.03) $ 0 $ (0.23) $ (0.03)
Diluted net loss per common stock (in Dollars per share) [1] $ (0.03) $ 0 $ (0.23) $ (0.03)
Weighted average number of common shares outstanding        
Basic weighted average number of common shares outstanding (in Shares) [2] 20,194,804 15,004,004 18,146,456 15,004,004
Diluted weighted average number of common shares outstanding (in Shares) [2],[3] 20,194,804 15,004,004 18,146,456 15,004,004
[1] Share and per share data are presented on a retroactive basis to reflect the effects of (i) 1.55-for-1 forward stock split of the common stock, and (ii) 4.5-for-1 forward stock split of the Series A Super-Voting Preferred Stock effected on September 9, 2024.
[2] Earnings per share for basic and diluted weighted average shares outstanding are the same due to anti-dilutive effect resulting from the net loss for the three and nine months ended January 31, 2026.
[3] Loss per share for basic and diluted weighted average shares outstanding are the same due to anti-dilutive effect resulting from the net loss for the three and nine months ended January 31, 2026.  There were no diluted shares outstanding for the three and nine months ended January 31, 2026.